Among mucinous tumors, KRAS mutations are almost exclusively found in invasive mucinous adenocarcinomas (69%), with no KRAS mutations detected in adenocarcinoma in situ and colloid carcinoma. Here, KRAS is linked to mucinous adenocarcinoma.